Cue Biopharma Inc buy Stifel Nicolaus
Start price
22.03.23
/
50%
€3.00
Target price
22.03.24
€7.41
Performance (%)
-42.17%
End price
23.03.24
€1.74
Summary
This prediction ended on 23.03.24 with a price of €1.74. The BUY prediction by Stifel_Nicolaus for Cue Biopharma Inc performed very badly with a performance of -42.17%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cue Biopharma Inc | - | - | - | - |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten